Moran ben David
Director/Miembro de la Junta en Immunyx Pharma Ltd. .
Perfil
As Chief Business Development Officer at VLX, Moran brings with her a rich interdisciplinary background and skills at the cross-section of pharma drug development, biology and business and IP law from blockbuster-drugs IP litigation, to evaluation of new technologies, biological and business opportunities as well as management of collaborations worldwide.
Prior to joining VLX, Moran was Head of Business Development at Pharma Two B in Israel and held various business, strategy, and technological leadership positions in global strategic partnership and alliance management at GlaxoSmithKline, Novartis, and Takeda in Boston.
Moran is seasoned in establishing partnerships for early stage innovative projects and clinical development.
Before joining the pharmaceutical industry, Moran was a practicing lawyer, specializing in patent litigation for pharmaceutical companies.
Moran holds a BS in Biology from Tel Aviv University, a dual degree from IDC in Finance and Law, and an MBA from Boston University.
Cargos activos de Moran ben David
Empresas | Cargo | Inicio |
---|---|---|
Immunyx Pharma Ltd.
Immunyx Pharma Ltd. Pharmaceuticals: GenericHealth Technology Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation. | Director/Miembro de la Junta | 01/04/2021 |
Van Leer Xenia Ventures
Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel. | Corporate Officer/Principal | 01/07/2019 |
Antiguos cargos conocidos de Moran ben David.
Empresas | Cargo | Fin |
---|---|---|
GSK PLC | Director/Miembro de la Junta | 02/05/2017 |
NOVARTIS AG | Director/Miembro de la Junta | 02/08/2016 |
Formación de Moran ben David.
Tel-Aviv University | Undergraduate Degree |
Questrom School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
NOVARTIS AG | Health Technology |
GSK PLC | Health Technology |
Empresas privadas | 2 |
---|---|
Van Leer Xenia Ventures
Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel. | Finance |
Immunyx Pharma Ltd.
Immunyx Pharma Ltd. Pharmaceuticals: GenericHealth Technology Immunyx Pharma Ltd. is based in New York, NY. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Immunyx Pharma Ltd. was founded by Seth Salpeter, Zvi Fridlender, and Zvika Granot. Seth Salpeter has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Moran ben David